
C in Canada 🇨🇦🇺🇸🌎😷
8.9K posts

C in Canada 🇨🇦🇺🇸🌎😷
@CJBro48
Mostly reposts. Politics, Climate Change, Photography, CovidCautious, Humour. Born 310.5 ppm.







🧵💉🇨🇦 Summary of where we stand on 2025 #Novavax access for Canada: There is obviously *a lot* of demand to bring @Novavax back to Canada, but I’ve noticed a lot of the energy is being used on the wrong pathways here. For a while now, there has been a very pervasive myth that Novavax is lacking approval in Canada. That is not true, Novavax’s JN.1 formulation received approval from Health Canada on September 19th, 2024, and remains approved today. Source: covid-vaccine.canada.ca/nuvaxovid-jn1/… So why was there no availability for the 2024 season? Essentially, there has been an ongoing dispute about the manufacturing location. The federal government's purchase contract with Novavax was dependent upon Novavax producing the doses in Canada. In 2021, Novavax planed to set up a manufacturing facility in Montreal, but that plan never materialized. As a result, the feds did not place any orders for the 2024 season, and they officially tore up the contract in March of this year: barrons.com/news/canada-ca… Even though the federal government, Public Services and Procurement Canada (PSPC) @PSPC_SPAC, and PHAC @PHAC_GC were not willing to place a purchase order, they did make it clear that individual provinces would still be able to place an order on their own. Most (or all) of the provinces investigated the possibility, but determined that they were unable to meet Novavax’s minimum order requirement, which has been reported as being 500,000 doses. In this article (cbc.ca/news/canada/ne…), Health Canada spokesperson Nicholas Janveau and New Brunswick Department of Health spokesperson Sean Hatchard both confirm the general idea: "However, Canada's current contract with Novavax only provides access to domestically manufactured vaccines, which Novavax has been unable to confirm for the 2024/25 season," Janveau said. If Novavax's JN.1 vaccine does get approved, provinces and territories "may choose to procure independently from Novavax from supply produced in India for their fall vaccination campaigns," he added. But "New Brunswick and other provinces have investigated and are unable to find other options to procure this vaccine," according to Department of Health spokesperson Sean Hatchard. "The amount of vaccine that needed to be ordered to procure it independently was too large based on the minimal demand in the province," he said.” This article (globalnews.ca/news/10789020/…) highlights the fact that most provinces were aware of the situation and also independently decided to either not place an order or that they could not meet the minimum requirement: “As of Tuesday afternoon, several provinces – including Alberta, Saskatchewan, Ontario, Nova Scotia, P.E.I. and Newfoundland and Labrador – confirmed to The Canadian Press that they aren’t placing orders for Nuvaxovid.” Things do have the opportunity to change this year, obviously, because we’re dealing with 2 new parties at the table - The @MarkJCarney administration, and @sanofi, who will be booking sales and distribution for Novavax beginning this year. However, in writing, Sanofi has told us this: “Please note that we do not plan to bring Nuvaxovid® to the Canadian market for the upcoming 2025 fall season at this time." But, we still need to push them for more details on where they stand, like trying to figure out if they would fulfill a purchase order from the federal government or a province if approached, and what their minimum purchase requirement would be. This recent letter (covidsociety.ca/wp-content/upl…) is a good start, sent to Sanofi’s Canadian office by @CanCovSoc and @immunocompCA. I’d encourage individuals to follow their lead of reaching out to Sanofi Canada to offer support but also demand more answers, as well as expressing your desire directly to the Carney administration, PSPC, and provincial leaders/health departments. The one thing that is NOT needed is to contact Health Canada or Novavax over the approvals process.









BREAKING: Qatar just told four countries their gas is not coming. For up to five years. QatarEnergy declared force majeure on long-term LNG contracts with Italy, Belgium, South Korea, and China on March 24. This is not a temporary disruption notice. This is the world’s largest LNG supplier telling major industrial economies that contractual obligations are suspended indefinitely because Iranian missiles destroyed the infrastructure required to fulfill them. The specifics matter. Iranian strikes on March 18 and 19 hit LNG Trains 4 and 6 at Ras Laffan Industrial City. Combined capacity: 12.8 million tonnes per annum. That is 17% of Qatar’s total LNG export capacity. QatarEnergy CEO Saad al-Kaabi told Reuters the damage will take three to five years to repair. Estimated annual revenue loss: $20 billion. ExxonMobil holds a 34% stake in Train S4 and 30% in Train S6. Shell is a partner in the damaged Pearl GTL facility, which will take approximately one year to repair. Train S4 supplied Italy’s Edison and Belgium’s EDFT. Train S6 supplied South Korea’s KOGAS, EDFT, and Shell’s operations in China. Those are not abstract numbers. Edison heats Italian homes. KOGAS powers South Korean industry. Shell’s China volumes feed the world’s largest energy importer. All of them just received force majeure notices with a repair timeline measured in years, not months. Al-Kaabi’s quote to Reuters is worth reading in full: “I never in my wildest dreams would have thought that Qatar would be in such an attack, especially from a brotherly Muslim country in the month of Ramadan, attacking us in this way.” Qatar accounts for roughly 20% of global LNG production. Approximately 80% of that went to Asia before the war. The country was in the middle of a $30 billion expansion to increase capacity from 77 MTPA to 142 MTPA by 2030. Al-Kaabi said the scale of the damage has set the region back 10 to 20 years. Now connect this to the rest of the matrix. Beyond LNG, QatarEnergy confirmed “materially reduced output” of condensate, LPG, helium, naphtha, and sulfur. Qatar produces one-third of the world’s helium. South Korea imports 64.7% of its helium from Qatar. Samsung and SK Hynix hold roughly six months of semiconductor-grade helium inventory. Helium spot prices have doubled. Even undamaged trains cannot export through a Strait of Hormuz where traffic has collapsed 95%, where 2,000 vessels are stranded, and where Iran is operating a selective vetting and toll system near Larak Island with at least two confirmed yuan-settled payments per Lloyd’s List. This force majeure is not a blip. It is three to five years of lost production compounding with a naval blockade, an insurance market that has priced itself out of the corridor, and a toll regime that Iran’s parliament is actively legislating into permanent law. Kuwait and Bahrain have also invoked force majeure. The dominoes are falling in sequence, not in parallel. The market is pricing a temporary oil shock. The molecule map says this is a multi-year structural reordering of global energy, semiconductors, and fertilizer supply chains running through a single contested waterway. open.substack.com/pub/shanakaans…













